This paper is only available as a PDF. To read, Please Download here.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Stroke and Cerebrovascular DiseasesAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Patent foramen ovale: A new risk factor for ischemic stroke.Heart Dis Stroke. 1993; 2: 235-241
- Handbuch für Artze und Studierende. Hirshwald, Berlin1877
- Transesophageal echocardiography in patients less than 60 years of age without obvious cardiac source of embolism.Neurol Res. 1994; 17: 368-372
- The prevalence of deep venous thrombosis in patients with suspected paradoxical embolism.Ann Intern Med. 1993; 119: 461-465
- Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography.Stroke. 1993; 24: 1865-1873
- Characteristics of patent foramen ovale associated with cryptogenic stroke.Stroke. 1994; 25: 582-586
- Patent foramen ovale: association between the degree of shunt by contrast transesophageal echocardiography and the risk of future ischemic neurologic events.Am Heart J. 1996; 131: 158-161
- Transcatheter closure of atrial septal defect or patent foramen ovale with the buttoned device for prevention of reccurrence of paradoxical embolism.Am J Cardiol. 1996; 78: 233-236
- Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack.Am Heart J. 1995; 130: 1083-1088
- Aortogenic embolic stroke: A transesophageal echocardiographic approach.Stroke. 1992; 23: 1056-1061
- The prevalence of ulcerated plaques in the aortic arch in patients with stroke.N Engl J Med. 1992; 326: 221-225
- Atherosclerotic disease of the aortic arch and the risk of ischemic stroke.N Engl J Med. 1994; 331: 1474-1479
- Proximal aortic atheroma. An independent risk factor for cerebral ischemia.Stroke. 1995; 26: 218-224
- Protruding aortic atheromas predict stroke in elderly patients undergoing cardiopulmonary bypass.J Am Coll Cardiol. 1992; 20: 70-77
- Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke.N Engl J Med. 1996; 334: 1216-1221
- Variable effect of anticoagulation in the treatment of severe protruding atherosclerotic aortic debris.Am Heart J. 1995; 127: 1645-1647
- Excision of focal aortic arch atheroma using deep hypothermic circulatory arrest.Ann Thorac Surg. 1995; 60: 457-458
- Sneddon's syndrome is a thrombotic vasculopathy: neuropathologic and neuroradiologic evidence.Neurology. 1995; 45: 557-560
- Anticardiolipin antibodies are an independent risk factor for first ischemic stroke.Neurology. 1993; 43: 2069-2073
- The management of thrombosis in the antiphospholipid-antibody syndrome.N Engl J Med. 1995; 332: 993-997
- Recurrent stroke and thrombo-occlusive events in the antiphospholipid syndrome.Ann Neurol. 1995; 38: 119-124
- Antiphospholipid thrombosis: clinical course after first thrombotic event in 70 patients.Ann Intern Med. 1992; 117: 303-308
- Prothrombotic states in young people with idiopathic stroke: a prospective study.Stroke. 1994; 25: 287-290
- Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thrombosis.Blood. 1995; 85: 607-614
- Factor V Leiden mutation in cerebral venous thrombosis.Stroke. 1996; 27: 1721-1723
- Factor V gene mutation is a risk factor for cerebral venous thrombosis.Thromb Haemost. 1996; 75: 393-394
- Mutation in the gene coding for coagulation V and the risk of myocardial infarction, stroke and venous thrombosis in apparently healthy men.N Engl J Med. 1995; 332: 912-917
- Factor V Leiden gene mutation and thrombin generation in relation to the development of acute stroke.Arterioscler Thromb Vasc Biol. 1995; 15 (PR): 783-785
- The prevalence of poor anticoagulant response to protein C (APC resistance) among patients suffering from stroke or venous thrombosis and healthy subjects.Blood Coag Fibrinol. 1994; 5: 51-57
- Activated protein C resistance in cases of cerebral infarction.Lancet. 1995; 345: 795
- Reduced response to activated protein C is associated with increased risk for cerebrovascular disease.Ann Intern Med. 1996; 125: 265-269
- Activated protein C resistance in ischemic stroke not due to factor V arginine506→glutamine mutation.Stroke. 1996; 27: 1163-1166
Article info
Identification
Copyright
© 1997 National Stroke Association. All rights reserved. Published by Elsevier Inc.
